Literature DB >> 5313197

Methyldopa and associated thrombocytopenia.

S M Manohitharajah, W J Jenkins, P D Roberts, R C Clarke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5313197      PMCID： PMC1795213          DOI： 10.1136/bmj.1.5747.494

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  THROMBOPENIA AFTER USE OF METHYLDOPA.

Authors:  A H BENRAAD; A H SCHOENAKER
Journal:  Lancet       Date:  1965-08-07       Impact factor: 79.321

2.  Methyldopa-induced thrombocytopenia.

Authors:  A Ten Pas; N K de Leeuw; C H Stacey
Journal:  Can Med Assoc J       Date:  1966-08-13       Impact factor: 8.262

3.  Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy.

Authors:  S M Worlledge; K C Carstairs; J V Dacie
Journal:  Lancet       Date:  1966-07-16       Impact factor: 79.321

4.  Agranulocytosis caused by methyl dopa (Aldomet).

Authors:  G P HALLWRIGHT
Journal:  N Z Med J       Date:  1961-12
  4 in total
  1 in total

1.  Drug-induced thrombocytopenia.

Authors:  P J Handagama; B F Feldman
Journal:  Vet Res Commun       Date:  1986-01       Impact factor: 2.459
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.